Healthcare -
Biotechnology - NASDAQ - US
$ 13.52
-1.1 %
$ 1.58 B
Market Cap
-8.1
P/E
Price Target
Average
35.60%
Revenue Forecast
Estimate
134.62%
EBIT
Estimate
38.18%
Net Income
Estimate
37.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arcutis Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ARQT of $18.3 , with forecasts ranging from
a
low of
$18 to a high of $19 .
ARQT Lowest Price Target
Wall Street Target
18 USD
33.14%
ARQT Average Price Target
Wall Street Target
18.3 USD
35.60%
ARQT Highest Price Target
Wall Street Target
19 USD
40.53%
REVENUE FORECAST
Revenue Forecast Chart ARQT
EBIT FORECAST
EBIT Forecast Chart ARQT
NET INCOME FORECAST
Net Income Chart ARQT